Business Description
HOOKIPA Pharma Inc
NAICS : 325412
SIC : 2834
ISIN : US43906K1007
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.85 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.09 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -3.25 | |||||
Beneish M-Score | -2.93 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -34.3 | |||||
3-Year EBITDA Growth Rate | 18.4 | |||||
3-Year EPS without NRI Growth Rate | 24.5 | |||||
3-Year FCF Growth Rate | 25.9 | |||||
3-Year Book Growth Rate | -44.3 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.68 | |||||
9-Day RSI | 63.72 | |||||
14-Day RSI | 60.67 | |||||
6-1 Month Momentum % | 53.74 | |||||
12-1 Month Momentum % | -26.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.5 | |||||
Quick Ratio | 3.5 | |||||
Cash Ratio | 2.79 | |||||
Days Sales Outstanding | 30.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -49.2 | |||||
Shareholder Yield % | -55.45 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -366.31 | |||||
Net Margin % | -405.29 | |||||
FCF Margin % | -306.44 | |||||
ROE % | -84.41 | |||||
ROA % | -47.99 | |||||
ROIC % | -177.12 | |||||
ROC (Joel Greenblatt) % | -398.8 | |||||
ROCE % | -63.07 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.66 | |||||
PB Ratio | 0.89 | |||||
Price-to-Tangible-Book | 0.89 | |||||
EV-to-EBIT | 0.33 | |||||
EV-to-EBITDA | 0.34 | |||||
EV-to-Revenue | -1.31 | |||||
EV-to-Forward-Revenue | 0.06 | |||||
EV-to-FCF | 0.43 | |||||
Price-to-Net-Current-Asset-Value | 1.06 | |||||
Price-to-Net-Cash | 1.75 | |||||
Earnings Yield (Greenblatt) % | 303.03 | |||||
FCF Yield % | -77.33 |